Annual EBITDA:
$19.31B+$1.03B(+5.61%)Summary
- As of today, BMY annual EBITDA is $19.31 billion, with the most recent change of +$1.03 billion (+5.61%) on December 31, 2024.
- During the last 3 years, BMY annual EBITDA has fallen by -$990.00 million (-4.88%).
- BMY annual EBITDA is now -4.88% below its all-time high of $20.30 billion, reached on December 31, 2021.
Performance
BMY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$4.87B-$275.00M(-5.34%)Summary
- As of today, BMY quarterly EBITDA is $4.87 billion, with the most recent change of -$275.00 million (-5.34%) on September 30, 2025.
- Over the past year, BMY quarterly EBITDA has increased by +$17.00 million (+0.35%).
- BMY quarterly EBITDA is now -9.06% below its all-time high of $5.36 billion, reached on March 31, 2022.
Performance
BMY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$18.97B+$17.00M(+0.09%)Summary
- As of today, BMY TTM EBITDA is $18.97 billion, with the most recent change of +$17.00 million (+0.09%) on September 30, 2025.
- Over the past year, BMY TTM EBITDA has increased by +$462.00 million (+2.50%).
- BMY TTM EBITDA is now -5.64% below its all-time high of $20.10 billion, reached on December 31, 2022.
Performance
BMY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BMY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +5.6% | +0.3% | +2.5% |
| 3Y3 Years | -4.9% | +8.5% | -4.9% |
| 5Y5 Years | +134.1% | +21.7% | +46.6% |
BMY EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -4.9% | +5.6% | -5.3% | +19.1% | -5.6% | +8.7% |
| 5Y | 5-Year | -4.9% | +134.1% | -9.1% | +40.5% | -5.6% | +46.6% |
| All-Time | All-Time | -4.9% | +3701.0% | -9.1% | +184.8% | -5.6% | +620.0% |
BMY EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $4.87B(-5.3%) | $18.97B(+0.1%) |
| Jun 2025 | - | $5.15B(+13.1%) | $18.95B(+0.0%) |
| Mar 2025 | - | $4.55B(+3.4%) | $18.95B(+2.5%) |
| Dec 2024 | $19.31B(+5.6%) | $4.40B(-9.4%) | $18.49B(-0.1%) |
| Sep 2024 | - | $4.85B(-5.7%) | $18.50B(+1.6%) |
| Jun 2024 | - | $5.14B(+25.8%) | $18.20B(+4.3%) |
| Mar 2024 | - | $4.09B(-7.4%) | $17.45B(-4.4%) |
| Dec 2023 | $18.28B(-6.5%) | $4.42B(-3.1%) | $18.26B(-3.2%) |
| Sep 2023 | - | $4.55B(+3.7%) | $18.87B(+0.4%) |
| Jun 2023 | - | $4.39B(-10.3%) | $18.81B(-4.3%) |
| Mar 2023 | - | $4.90B(-2.5%) | $19.64B(-2.3%) |
| Dec 2022 | $19.56B(-3.7%) | $5.03B(+12.0%) | $20.10B(+0.8%) |
| Sep 2022 | - | $4.49B(-14.2%) | $19.95B(+0.1%) |
| Jun 2022 | - | $5.23B(-2.4%) | $19.93B(+5.4%) |
| Mar 2022 | - | $5.36B(+10.0%) | $18.90B(+2.3%) |
| Dec 2021 | $20.30B(+35.5%) | $4.87B(+8.8%) | $18.48B(+8.2%) |
| Sep 2021 | - | $4.48B(+6.5%) | $17.07B(+2.9%) |
| Jun 2021 | - | $4.20B(-14.8%) | $16.60B(+3.9%) |
| Mar 2021 | - | $4.93B(+42.3%) | $15.98B(+10.6%) |
| Dec 2020 | $14.98B(+81.6%) | $3.47B(-13.4%) | $14.45B(+11.7%) |
| Sep 2020 | - | $4.00B(+11.7%) | $12.94B(+18.4%) |
| Jun 2020 | - | $3.58B(+5.5%) | $10.92B(+14.5%) |
| Mar 2020 | - | $3.40B(+74.0%) | $9.54B(+17.6%) |
| Dec 2019 | $8.25B(+16.2%) | $1.95B(-1.8%) | $8.11B(+2.2%) |
| Sep 2019 | - | $1.99B(-9.7%) | $7.94B(+1.7%) |
| Jun 2019 | - | $2.20B(+11.8%) | $7.81B(+23.2%) |
| Mar 2019 | - | $1.97B(+10.6%) | $6.34B(+7.0%) |
| Dec 2018 | $7.10B(+16.1%) | $1.78B(-4.2%) | $5.92B(+9.8%) |
| Sep 2018 | - | $1.86B(+153.8%) | $5.39B(+12.2%) |
| Jun 2018 | - | $732.00M(-52.8%) | $4.81B(-17.2%) |
| Mar 2018 | - | $1.55B(+24.2%) | $5.81B(-0.5%) |
| Dec 2017 | $6.11B(+5.3%) | $1.25B(-1.7%) | $5.84B(+1.4%) |
| Sep 2017 | - | $1.27B(-26.6%) | $5.76B(-3.6%) |
| Jun 2017 | - | $1.73B(+9.4%) | $5.97B(+3.7%) |
| Mar 2017 | - | $1.58B(+35.3%) | $5.76B(+3.0%) |
| Dec 2016 | $5.80B(+25.6%) | $1.17B(-21.5%) | $5.59B(+12.1%) |
| Sep 2016 | - | $1.49B(-1.9%) | $4.99B(+13.0%) |
| Jun 2016 | - | $1.52B(+7.3%) | $4.42B(+35.7%) |
| Mar 2016 | - | $1.42B(+149.3%) | $3.26B(+2.8%) |
| Dec 2015 | $4.62B(+16.6%) | $568.00M(-38.0%) | $3.17B(-14.0%) |
| Sep 2015 | - | $916.00M(+156.6%) | $3.68B(+1.7%) |
| Jun 2015 | - | $357.00M(-73.1%) | $3.62B(-14.8%) |
| Mar 2015 | - | $1.33B(+22.3%) | $4.25B(+8.3%) |
| Dec 2014 | $3.96B(-10.7%) | $1.08B(+26.6%) | $3.93B(-6.6%) |
| Sep 2014 | - | $856.00M(-13.3%) | $4.21B(-7.5%) |
| Jun 2014 | - | $987.00M(-1.4%) | $4.54B(-1.6%) |
| Mar 2014 | - | $1.00B(-26.5%) | $4.62B(+1.8%) |
| Dec 2013 | $4.44B(-15.5%) | $1.36B(+13.9%) | $4.54B(+8.6%) |
| Sep 2013 | - | $1.20B(+12.8%) | $4.17B(+9.0%) |
| Jun 2013 | - | $1.06B(+15.1%) | $3.83B(-7.0%) |
| Mar 2013 | - | $920.00M(-8.0%) | $4.12B(-21.2%) |
| Dec 2012 | $5.26B(-30.4%) | $1.00B(+17.6%) | $5.23B(-13.5%) |
| Sep 2012 | - | $850.00M(-36.9%) | $6.04B(-15.6%) |
| Jun 2012 | - | $1.35B(-33.6%) | $7.15B(-8.0%) |
| Mar 2012 | - | $2.03B(+11.9%) | $7.78B(+2.9%) |
| Dec 2011 | $7.55B(+9.8%) | $1.81B(-7.6%) | $7.56B(+2.2%) |
| Sep 2011 | - | $1.96B(-0.4%) | $7.39B(+2.6%) |
| Jun 2011 | - | $1.97B(+9.0%) | $7.20B(+3.5%) |
| Mar 2011 | - | $1.81B(+9.7%) | $6.96B(+1.6%) |
| Dec 2010 | $6.88B(+19.5%) | $1.65B(-7.3%) | $6.85B(+17.1%) |
| Sep 2010 | - | $1.78B(+2.7%) | $5.85B(-0.8%) |
| Jun 2010 | - | $1.73B(+2.1%) | $5.90B(-1.4%) |
| Mar 2010 | - | $1.70B(+160.8%) | $5.98B(+3.3%) |
| Dec 2009 | $5.75B(+1.1%) | $650.00M(-64.3%) | $5.79B(-10.6%) |
| Sep 2009 | - | $1.82B(+0.7%) | $6.48B(+5.5%) |
| Jun 2009 | - | $1.81B(+20.3%) | $6.14B(+7.5%) |
| Mar 2009 | - | $1.51B(+12.7%) | $5.71B(-0.3%) |
| Dec 2008 | $5.69B(+22.2%) | $1.34B(-10.2%) | $5.73B(+8.1%) |
| Sep 2008 | - | $1.49B(+7.6%) | $5.30B(+3.2%) |
| Jun 2008 | - | $1.38B(-9.2%) | $5.14B(+2.4%) |
| Mar 2008 | - | $1.52B(+67.7%) | $5.02B(+9.6%) |
| Dec 2007 | $4.66B(+30.5%) | $908.00M(-31.5%) | $4.58B(+10.6%) |
| Sep 2007 | - | $1.33B(+5.0%) | $4.14B(+14.4%) |
| Jun 2007 | - | $1.26B(+16.7%) | $3.62B(-0.7%) |
| Mar 2007 | - | $1.08B(+130.7%) | $3.64B(-3.7%) |
| Dec 2006 | $3.57B(-29.4%) | $469.00M(-41.7%) | $3.78B(-15.8%) |
| Sep 2006 | - | $804.00M(-37.6%) | $4.49B(-8.7%) |
| Jun 2006 | - | $1.29B(+5.5%) | $4.92B(-1.8%) |
| Mar 2006 | - | $1.22B(+3.7%) | $5.01B(-0.9%) |
| Dec 2005 | $5.05B | $1.18B(-4.4%) | $5.05B(+3.6%) |
| Sep 2005 | - | $1.23B(-10.5%) | $4.88B(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2005 | - | $1.38B(+8.5%) | $5.06B(+9.7%) |
| Mar 2005 | - | $1.27B(+26.7%) | $4.61B(-1.8%) |
| Dec 2004 | $5.61B(-4.2%) | $1.00B(-29.3%) | $4.70B(-5.1%) |
| Sep 2004 | - | $1.42B(+52.6%) | $4.95B(-2.8%) |
| Jun 2004 | - | $928.00M(-31.4%) | $5.10B(-9.2%) |
| Mar 2004 | - | $1.35B(+7.7%) | $5.61B(+0.6%) |
| Dec 2003 | $5.85B(+20.6%) | $1.26B(-19.4%) | $5.58B(+19.9%) |
| Sep 2003 | - | $1.56B(+7.8%) | $4.66B(+11.6%) |
| Jun 2003 | - | $1.45B(+9.4%) | $4.17B(+2.0%) |
| Mar 2003 | - | $1.32B(+299.6%) | $4.09B(+10.9%) |
| Dec 2002 | $4.85B(-17.6%) | $330.80M(-69.2%) | $3.69B(-27.3%) |
| Sep 2002 | - | $1.07B(-21.2%) | $5.08B(+5.4%) |
| Jun 2002 | - | $1.36B(+48.2%) | $4.82B(-5.3%) |
| Mar 2002 | - | $921.00M(-46.3%) | $5.09B(-15.3%) |
| Dec 2001 | $5.89B(-12.6%) | $1.72B(+110.2%) | $6.00B(-1.3%) |
| Sep 2001 | - | $816.00M(-50.1%) | $6.08B(-12.9%) |
| Jun 2001 | - | $1.63B(-11.2%) | $6.98B(-0.4%) |
| Mar 2001 | - | $1.84B(+2.7%) | $7.01B(+0.0%) |
| Dec 2000 | $6.73B(+3.1%) | $1.79B(+4.6%) | $7.00B(+2.3%) |
| Sep 2000 | - | $1.71B(+3.3%) | $6.85B(+0.6%) |
| Jun 2000 | - | $1.66B(-9.7%) | $6.81B(+3.2%) |
| Mar 2000 | - | $1.84B(+12.4%) | $6.60B(+3.6%) |
| Dec 1999 | $6.53B(+13.7%) | $1.64B(-2.4%) | $6.37B(+2.4%) |
| Sep 1999 | - | $1.68B(+15.5%) | $6.22B(+2.9%) |
| Jun 1999 | - | $1.45B(-9.9%) | $6.05B(+2.4%) |
| Mar 1999 | - | $1.61B(+8.3%) | $5.91B(+2.8%) |
| Dec 1998 | $5.75B(+14.3%) | $1.49B(-1.0%) | $5.75B(+4.1%) |
| Sep 1998 | - | $1.50B(+14.7%) | $5.52B(+3.1%) |
| Jun 1998 | - | $1.31B(-9.5%) | $5.35B(+2.7%) |
| Mar 1998 | - | $1.45B(+14.9%) | $5.21B(+3.6%) |
| Dec 1997 | $5.03B(+12.5%) | $1.26B(-5.8%) | $5.03B(+3.5%) |
| Sep 1997 | - | $1.34B(+14.5%) | $4.86B(+3.2%) |
| Jun 1997 | - | $1.17B(-7.9%) | $4.71B(+2.6%) |
| Mar 1997 | - | $1.27B(+16.6%) | $4.59B(+2.5%) |
| Dec 1996 | $4.47B(+10.1%) | $1.09B(-8.3%) | $4.47B(+0.8%) |
| Sep 1996 | - | $1.19B(+13.4%) | $4.44B(+3.3%) |
| Jun 1996 | - | $1.05B(-9.3%) | $4.30B(+2.3%) |
| Mar 1996 | - | $1.15B(+9.6%) | $4.20B(+3.3%) |
| Dec 1995 | $4.06B(+14.5%) | $1.05B(+0.7%) | $4.06B(+5.7%) |
| Sep 1995 | - | $1.04B(+10.2%) | $3.85B(+2.4%) |
| Jun 1995 | - | $948.00M(-6.9%) | $3.76B(+2.6%) |
| Mar 1995 | - | $1.02B(+22.1%) | $3.66B(+3.1%) |
| Dec 1994 | $3.55B(+10.5%) | $834.00M(-12.8%) | $3.55B(+22.8%) |
| Sep 1994 | - | $956.00M(+12.2%) | $2.89B(+2.0%) |
| Jun 1994 | - | $852.00M(-6.2%) | $2.83B(+2.5%) |
| Mar 1994 | - | $908.00M(+415.9%) | $2.77B(+2.0%) |
| Dec 1993 | $3.21B(+42.4%) | $176.00M(-80.4%) | $2.71B(+15.5%) |
| Sep 1993 | - | $899.00M(+15.0%) | $2.35B(+0.7%) |
| Jun 1993 | - | $782.00M(-8.4%) | $2.33B(+1.8%) |
| Mar 1993 | - | $854.00M(+554.3%) | $2.29B(+1.5%) |
| Dec 1992 | $2.25B(-25.1%) | -$188.00M(-121.3%) | $2.25B(-26.8%) |
| Sep 1992 | - | $883.00M(+19.3%) | $3.08B(+1.1%) |
| Jun 1992 | - | $740.00M(-9.8%) | $3.05B(-0.2%) |
| Mar 1992 | - | $820.00M(+28.3%) | $3.05B(+1.4%) |
| Dec 1991 | $3.01B(+14.4%) | $639.00M(-24.7%) | $3.01B(+3.6%) |
| Sep 1991 | - | $849.00M(+14.0%) | $2.91B(+2.6%) |
| Jun 1991 | - | $745.00M(-4.4%) | $2.83B(+2.9%) |
| Mar 1991 | - | $779.00M(+45.9%) | $2.75B(+4.6%) |
| Dec 1990 | $2.63B(+23.4%) | $534.00M(-31.2%) | $2.63B(+172.2%) |
| Sep 1990 | - | $776.00M(+16.5%) | -$3.65B(-73.4%) |
| Jun 1990 | - | $666.00M(+1.4%) | -$2.10B(-300.6%) |
| Mar 1990 | - | $657.00M(+111.4%) | -$525.00M(-148.5%) |
| Dec 1989 | $2.13B(+47.4%) | -$5.75B(-347.7%) | $1.08B(-50.4%) |
| Sep 1989 | - | $2.32B(+3.4%) | $2.19B(+6.0%) |
| Jun 1989 | - | $2.24B(-0.9%) | $2.06B(+7.5%) |
| Mar 1989 | - | $2.27B(+148.8%) | $1.92B(+8.4%) |
| Dec 1988 | $1.45B(+7.0%) | -$4.64B(-311.5%) | $1.77B(-20.0%) |
| Sep 1988 | - | $2.20B(+4.5%) | $2.21B(+16.1%) |
| Jun 1988 | - | $2.10B(-0.8%) | $1.91B(+12.5%) |
| Mar 1988 | - | $2.12B(+150.4%) | $1.69B(+15.5%) |
| Dec 1987 | $1.35B(+36.5%) | -$4.20B(-322.4%) | $1.47B(-74.1%) |
| Sep 1987 | - | $1.89B(0.0%) | $5.67B(+50.0%) |
| Jun 1987 | - | $1.89B(0.0%) | $3.78B(+100.0%) |
| Mar 1987 | - | $1.89B | $1.89B |
| Dec 1986 | $991.20M(+17.5%) | - | - |
| Dec 1985 | $843.50M(+6.3%) | - | - |
| Dec 1984 | $793.80M(+11.4%) | - | - |
| Dec 1983 | $712.30M(+13.1%) | - | - |
| Dec 1982 | $629.90M(+10.0%) | - | - |
| Dec 1981 | $572.40M(+12.7%) | - | - |
| Dec 1980 | $508.00M | - | - |
FAQ
- What is Bristol-Myers Squibb Company annual EBITDA?
- What is the all-time high annual EBITDA for Bristol-Myers Squibb Company?
- What is Bristol-Myers Squibb Company annual EBITDA year-on-year change?
- What is Bristol-Myers Squibb Company quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Bristol-Myers Squibb Company?
- What is Bristol-Myers Squibb Company quarterly EBITDA year-on-year change?
- What is Bristol-Myers Squibb Company TTM EBITDA?
- What is the all-time high TTM EBITDA for Bristol-Myers Squibb Company?
- What is Bristol-Myers Squibb Company TTM EBITDA year-on-year change?
What is Bristol-Myers Squibb Company annual EBITDA?
The current annual EBITDA of BMY is $19.31B
What is the all-time high annual EBITDA for Bristol-Myers Squibb Company?
Bristol-Myers Squibb Company all-time high annual EBITDA is $20.30B
What is Bristol-Myers Squibb Company annual EBITDA year-on-year change?
Over the past year, BMY annual EBITDA has changed by +$1.03B (+5.61%)
What is Bristol-Myers Squibb Company quarterly EBITDA?
The current quarterly EBITDA of BMY is $4.87B
What is the all-time high quarterly EBITDA for Bristol-Myers Squibb Company?
Bristol-Myers Squibb Company all-time high quarterly EBITDA is $5.36B
What is Bristol-Myers Squibb Company quarterly EBITDA year-on-year change?
Over the past year, BMY quarterly EBITDA has changed by +$17.00M (+0.35%)
What is Bristol-Myers Squibb Company TTM EBITDA?
The current TTM EBITDA of BMY is $18.97B
What is the all-time high TTM EBITDA for Bristol-Myers Squibb Company?
Bristol-Myers Squibb Company all-time high TTM EBITDA is $20.10B
What is Bristol-Myers Squibb Company TTM EBITDA year-on-year change?
Over the past year, BMY TTM EBITDA has changed by +$462.00M (+2.50%)